about
Transarterial Therapies for Hepatocellular CarcinomaIncreased expression of stathmin and elongation factor 1α in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients.β-Catenin activated hepatocellular adenoma: a report of three cases in KoreaIncreased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior.Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis.Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma.Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection.Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.Histological characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on gadoxetic acid-enhanced MR imaging.IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study.Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma.Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1/2-AP1 and SP1 axis.Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteriaIncreased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis.The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial RadioembolizationDynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise HepatocarcinogenesisA proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significanceHepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic FeaturesHepatic sarcomatoid carcinoma: magnetic resonance imaging evaluation by using the liver imaging reporting and data systemA dichotomous imaging classification for cholangiocarcinomas based on new histologic conceptsVessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular CarcinomaAlpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular CarcinomaDiagnostic performance of Liver Imaging Reporting and Data System in patients at risk of both hepatocellular carcinoma and metastasis
P50
Q28072845-FC2D169F-5840-45DD-A147-BFE7B0FB254EQ33728805-3EB61CA6-71B4-43E8-B827-0870AE26AEBEQ33959608-A78DF3AC-2B8B-474F-82A4-A50EAD915582Q34050895-8D53352A-5CA4-441E-AE6A-4F97BAA0FDB8Q35978719-970D95AD-0EA9-4873-A55B-FEAC624ECCF0Q36257609-0AAC9A1B-B1AC-419B-B9B1-670E95FF0483Q36300899-E490C3AF-2333-4356-AE49-A0419F4308E4Q36325824-66A66262-B4A8-48D9-998C-CC89B729A372Q38055362-354B47F5-7CFE-4649-9843-6E10DE33E4A0Q38058687-85DF6C04-BE46-43BB-BA82-2B28994DC316Q38370432-72F394C9-4C7E-4412-91F8-90AB0DEC2BBCQ39259950-9DCE3376-AA8E-4039-9117-E7A26DA8BAB8Q40151513-D4C4D0EB-4A65-46B8-B213-F3EFA7E76150Q46105464-D661CB7C-E174-4768-BD12-18A819862047Q46256483-9564AB99-4F7C-46B1-9842-FB0E8D5D3C08Q47136607-39C13B70-8AB5-4727-B73A-DDBAB324D638Q47825611-6C1BFB7D-44F8-4927-9F7E-BAD1A1750056Q47843273-DD3220EC-730B-4C23-9958-5A5B72CD4570Q48095053-FBD3DD71-5005-4410-AEE7-03109BD60426Q48196778-6FE1E64D-E4AA-4C7A-96FC-DC7143496FC2Q53525275-81F15776-874E-4A88-928A-2E52F912076BQ64936900-37E22D93-B3CA-45D3-8C4A-F100B11328A4Q89681374-F25213D7-7D83-4821-8CE2-02EB6C60EF84Q90044008-53ACD0DB-4015-4656-BF67-A7BE1893A078Q90601719-06521881-EA01-45A3-B181-5F9ED92C8134Q91990910-8BAE31D6-4EAE-431D-9EE0-C264C2C7F706Q92287980-E69BDAA1-B81C-4EFD-B8D3-F580E0970E31Q92715130-1481DA89-C148-4E21-AC6C-D606B37EF108Q92805362-52BDBE16-7707-4C27-9BA9-65ACCF60E3C0Q92997493-7051ED7B-1380-4086-B866-26E4CFDFB527Q95644274-356332AF-4A43-4185-9C08-53086DA7AC0C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hyungjin Rhee
@ast
Hyungjin Rhee
@en
Hyungjin Rhee
@es
Hyungjin Rhee
@nl
Hyungjin Rhee
@sl
type
label
Hyungjin Rhee
@ast
Hyungjin Rhee
@en
Hyungjin Rhee
@es
Hyungjin Rhee
@nl
Hyungjin Rhee
@sl
prefLabel
Hyungjin Rhee
@ast
Hyungjin Rhee
@en
Hyungjin Rhee
@es
Hyungjin Rhee
@nl
Hyungjin Rhee
@sl
P106
P1153
55268406500
P31
P496
0000-0001-7759-4458